New drug target, i.e., the activin pathway can solve two problems often faced by lung cancer patients one is developing resistance to chemotherapy, and another one is kidney damage when chemotherapy dose is increased, finds a new study. The findings of this study are published in the journal of iScience Translational Medicine/i.
A naturally occurring hormone could help make chemotherapy much more effective for many Australians with lung cancer And the hormone - known as follistatin - also ...
New drug target, i.e., the activin pathway can solve two problems often faced by lung cancer patients one is developing resistance to chemotherapy, and another one is kidney damage when chemotherapy dose is increased, finds a new study. The findings of this study are published in the journal of iScience Translational Medicine/i.
A naturally occurring hormone could help make chemotherapy much more effective for many Australians with lung cancer And the hormone - known as follistatin - also ...